U.S. News & World Report reported on research shared at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, on the impact testosterone therapy might have on those undergoing knee replacement surgery. 

Brian Chalmers, MD, hip and knee surgeon at HSS shared, "With more people taking this hormone than ever, and (knee replacement) surgeries expected to exceed 1 million per year by 2030, we wanted to dive deeper into the question of testosterone’s post-surgical effects.” 

Patients who took testosterone within a year of their surgery had a higher risk of infection, blood clots, kidney damage, pneumonia and knee instability after the procedure, researchers reported.

Read the full article at usnews.com.